#orforglipron
#orforglipron
[ follow ]
#eli-lilly #obesity-treatment #weight-loss #glp-1 #obesity #weight-loss-drugs #diabetes #oral-glp-1 #phase-3-trial
Medicine
fromwww.independent.co.uk
2 weeks agoVital breakthrough as once-a-day pill can help people lose significant' weight
Orforglipron, a once-daily pill, produced significant weight loss and could increase access to obesity treatment while The Independent solicits donations to fund open journalism.
fromwww.theguardian.com
2 weeks agoDaily weight loss pill can help cut body weight by a fifth, trial shows
A daily pill for weight loss can help people reduce their body weight by as much as a fifth, according to a trial that could pave the way for millions more people to shed pounds. The drug, called orforglipron, is manufactured by Eli Lilly and targets the same GLP-1 receptors as weight loss injections such as Mounjaro and Wegovy. In a trial of 3,127 adults, one in five people who took the once-a-day tablet for 72 weeks lost 20% or more of their body weight.
Medicine
fromFast Company
2 weeks agoThis weight-loss pill by Lilly could be FDA-approved by end of 2025
"FDA policymakers have tried to come up with ideas to speed important products to market. ... It is in part directed to achieving some of the (Trump) Administration's goals," said Chad Landmon, chair of Polsenelli's patent and FDA practice.
Medicine
[ Load more ]